<DOC>
	<DOCNO>NCT02770326</DOCNO>
	<brief_summary>The purpose study test safety FMT patient C. difficile cancer . In previous study , FMT show cure C. difficile antibiotic fail , study include patient cancer . The investigator want prove FMT safe group people doctor feel comfortable prescribe patient cancer .</brief_summary>
	<brief_title>Safety Stool Transplant Patients With Difficult Treat C. Difficile Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<criteria>≥18 year old Patients solid organ malignancy receive chemotherapy within past six month . Clinical microbiologic relapse C. difficile associate diarrhea least one course adequate antibiotic therapy refractory disease respond treatment . At least 10 day vancomycin least 125mg QID , metronidazole 500mg TID C. difficile associate diarrhea define : ≥3 loose watery stool per day least 2 consecutive day ≥8 loose stool 48 hour Positive Clostridium difficile PCR Life expectancy &gt; 3 month . Expected prolong compromised immunity HIV infection CD4 count &lt; 240 History hematopoietic stem cell transplant ( HSCT ) Hematologic malignancy ANC &lt; 1000/mm3 Contraindications anesthesia procedure Serious cardiopulmonary comorbidities Inability tolerate anesthesia HGB &lt; 8 g/dL Risk bleeding procedure PLT &lt; 50,000 K/mcL INR &gt; 1.5 INR Pregnancy Pregnant patient exclude study . Gastrointestinal ( GI ) contraindication Inflammatory bowel disease Active fistula Small bowel obstruction Ileus Gastroparesis Nausea vomit Gastrointestinal surgery within previous 3 month Patients receive immunotherapy , colitis know adverse event therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Safety Stool Transplant</keyword>
	<keyword>Fecal Microbiota Transplantation ( FMT )</keyword>
	<keyword>15-337</keyword>
</DOC>